Additionally, IL-22 levels were found to be increased in the skin of patients with AD, ACD, and allergic asthma (Jia and Wu 2014) and IL-22 has been suggested as a potential biomarker for allergic disease (Zissler et al. 2016). The gene discussed is IL22; the disease is granular corneal dystrophy type II.